UnknownNot Applicable

Cavernous Transformation of Portal Vein： Etiology, Diagnosis, Management and Prognosis

China150 participantsStarted 2010-10

Plain-language summary

To observe the etiology, diagnosis, management and prognosis of cavernous transformation of portal vein.

Who can participate

Age range1 Year – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients with CTPV. Exclusion Criteria: * Patients with known severe dysfunction of heart, lung, brain, kidney and other vital organs.

What they're measuring

Ascites Volume (mL)

Timeframe: 6 month

Hydrothorax Volume (mL)

Timeframe: 6 month

Trial details

NCT IDNCT02505113

SponsorSun Yat-sen University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-12

Contact for this trial

Zaibo Jiang, MD

+86 020 85253416 jiangzaibo@aliyun.com

View on ClinicalTrials.gov More Portal Vein, Cavernous Transformation Of trials